Research and intellectual property involving human material: after all, from whom are our genes?

This article discusses ethical, scientific and legal aspects of the patenting of human genes, starting from a historical context of intellectual property of living beings and passing through the decision of the US Supreme Court in Myriad Genetics case, conflict over patent of the genes BRCA1 and BRC...

Full description

Bibliographic Details
Main Authors:	Mariana de Melo Santos, Laura Melo Bonfim, Vanderson Assis Romualdo, Flávio Diniz Capanema
Format:	Article
Language:	English
Published:	Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict) da Fundação Oswaldo Cruz (Fiocruz) 2016-03-01
Series:	RECIIS
Subjects:	Patentes Genes Propriedade intelectual Pesquisa em genética Genes BRCA1 Gene BRCA2.
Online Access:	https://www.reciis.icict.fiocruz.br/index.php/reciis/article/view/1046

id	doaj-08366ae6a8b34b91bf8847314ece7328
record_format	Article
spelling	doaj-08366ae6a8b34b91bf8847314ece73282021-05-02T04:03:52ZengInstituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict) da Fundação Oswaldo Cruz (Fiocruz)RECIIS1981-62782016-03-0110110.29397/reciis.v10i1.1046984Research and intellectual property involving human material: after all, from whom are our genes?Mariana de Melo Santos0Laura Melo Bonfim1Vanderson Assis Romualdo2Flávio Diniz Capanema3Faculdade de Saúde e Ecologia Humana, Graduação em Medicina. Vespasiano, Minas Gerais, Brasil.Faculdade de Saúde e Ecologia Humana, Graduação em Medicina. Vespasiano, Minas Gerais, Brasil.Fundação Hospitalar do Estado de Minas Gerais, Comitê de Ética em Pesquisa. Belo Horizonte, Minas Gerais, Brasil.Fundação Hospitalar do Estado de Minas Gerais, Núcleo de Inovações Tecnológicas. Belo Horizonte, Minas Gerais, Brasil.This article discusses ethical, scientific and legal aspects of the patenting of human genes, starting from a historical context of intellectual property of living beings and passing through the decision of the US Supreme Court in Myriad Genetics case, conflict over patent of the genes BRCA1 and BRCA2, related to breast cancer and ovarian cancer. Moreover, the article discusses regulatory instruments on the subject, considering both the Brazilian and international legislation. Finally, it contrasts different positions on patent of human genes, adopting critical position that this matter deserves.https://www.reciis.icict.fiocruz.br/index.php/reciis/article/view/1046PatentesGenesPropriedade intelectualPesquisa em genéticaGenes BRCA1Gene BRCA2.
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Mariana de Melo Santos Laura Melo Bonfim Vanderson Assis Romualdo Flávio Diniz Capanema
spellingShingle	Mariana de Melo Santos Laura Melo Bonfim Vanderson Assis Romualdo Flávio Diniz Capanema Research and intellectual property involving human material: after all, from whom are our genes? RECIIS Patentes Genes Propriedade intelectual Pesquisa em genética Genes BRCA1 Gene BRCA2.
author_facet	Mariana de Melo Santos Laura Melo Bonfim Vanderson Assis Romualdo Flávio Diniz Capanema
author_sort	Mariana de Melo Santos
title	Research and intellectual property involving human material: after all, from whom are our genes?
title_short	Research and intellectual property involving human material: after all, from whom are our genes?
title_full	Research and intellectual property involving human material: after all, from whom are our genes?
title_fullStr	Research and intellectual property involving human material: after all, from whom are our genes?
title_full_unstemmed	Research and intellectual property involving human material: after all, from whom are our genes?
title_sort	research and intellectual property involving human material: after all, from whom are our genes?
publisher	Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict) da Fundação Oswaldo Cruz (Fiocruz)
series	RECIIS
issn	1981-6278
publishDate	2016-03-01
description	This article discusses ethical, scientific and legal aspects of the patenting of human genes, starting from a historical context of intellectual property of living beings and passing through the decision of the US Supreme Court in Myriad Genetics case, conflict over patent of the genes BRCA1 and BRCA2, related to breast cancer and ovarian cancer. Moreover, the article discusses regulatory instruments on the subject, considering both the Brazilian and international legislation. Finally, it contrasts different positions on patent of human genes, adopting critical position that this matter deserves.
topic	Patentes Genes Propriedade intelectual Pesquisa em genética Genes BRCA1 Gene BRCA2.
url	https://www.reciis.icict.fiocruz.br/index.php/reciis/article/view/1046
work_keys_str_mv	AT marianademelosantos researchandintellectualpropertyinvolvinghumanmaterialafterallfromwhomareourgenes AT lauramelobonfim researchandintellectualpropertyinvolvinghumanmaterialafterallfromwhomareourgenes AT vandersonassisromualdo researchandintellectualpropertyinvolvinghumanmaterialafterallfromwhomareourgenes AT flaviodinizcapanema researchandintellectualpropertyinvolvinghumanmaterialafterallfromwhomareourgenes
_version_	1721495367991689216

Research and intellectual property involving human material: after all, from whom are our genes?

Similar Items